Iroko Pharmaceuticals LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2007-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://iroko.com
Study of Naproxen Capsules to Treat Dental Pain
- First Posted Date
- 2010-10-27
- Last Posted Date
- 2012-05-22
- Lead Sponsor
- Iroko Pharmaceuticals, LLC
- Target Recruit Count
- 254
- Registration Number
- NCT01229228
- Locations
- 🇺🇸
Premier Research Group Limited, Austin, Texas, United States
Study of Diclofenac Capsules to Treat Dental Pain
Phase 2
Completed
- Conditions
- Dental Pain
- Interventions
- First Posted Date
- 2009-09-28
- Last Posted Date
- 2012-05-22
- Lead Sponsor
- Iroko Pharmaceuticals, LLC
- Target Recruit Count
- 202
- Registration Number
- NCT00985439
- Locations
- 🇺🇸
Premier Research Group Limited, Austin, Texas, United States
Phase 2 Study of Indomethacin Capsules to Treat Dental Pain
Phase 2
Completed
- Conditions
- Dental Pain
- Interventions
- First Posted Date
- 2009-08-25
- Last Posted Date
- 2012-05-22
- Lead Sponsor
- Iroko Pharmaceuticals, LLC
- Target Recruit Count
- 203
- Registration Number
- NCT00964431
- Locations
- 🇺🇸
Premier Research Group Limited, Austin, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath